In conclusion, this study sheds light on the role of gankyrin in triple-negative breast cancer and tumor ferroptosis, yet further research is needed to expand our understanding of gankyrin in different cancer types, overcome technical challenges, and uncover the underlying molecular mechanisms. Here, PSMD10 is linked to triple-negative breast carcinoma.